About Prof. Riesner
Prof. Riesner is a co-founder of QIAGEN. He has been on the Company's Supervisory Board since 1984 and was appointed Chairman of the Supervisory Board in 1999. Prof. Riesner has held the Chair of Biophysics at the Heinrich-Heine-University in DÃ¼sseldorf since 1980. In 1996, he was also appointed to the position of Vice President of Research, and in 1999, he was nominated Director of Technology at the University of DÃ¼sseldorf. Prior to that he was Professor of Biophysical Chemistry at the Darmstadt Institute of Technology and from 1975 to 1977, Lecturer of Biophysical Chemistry at Hannover Medical School. He has held guest professorships at the Institute of Microbiology, Academia Sinica, Beijing, and the Department of Neurology at the University of California, San Francisco. He received his M.S. in Physics from Hannover Institute of Technology and his Ph.D. from the University of Braunschweig, with post-graduate work at Princeton University. Professor Riesner is also a member of the supervisory board or a director of New Lab Bioquality, Erkrath; Therascope, Heidelberg; Kourion, DÃ¼sseldorf; Neuraxo, DÃ¼sseldorf; and Solutas HÃ¼rth.
Want to inform investors similar to Prof. Riesner about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Prof. Riesner News
Jun 27, 2013
By FinSMEs evocatal GmbH , a Düsseldorf, Germany-based enzyme specialist, closed a €3.5m Series B funding round. Backers included existing investors Roland Oetker, High-Tech Gründerfonds (HTGF) , Sirius Seedfonds Düsseldorf (SSFD) and business angel Prof. Riesner and new investors Nrw.Bank and Lanxess . The company intends to use the funds to extend its technology platform as well as its product portfolio. Led by CEO Dr. Thorsten Eggert, evocatal develops and produces enzymes and fine chemicals for the chemicals and pharmaceuticals industries. Its biocatalysts are employed for the synthesis of pharmaceutical compounds and chemical intermediates, as well as in the production of consumer goods – for example in the manufacture and refinement of textiles, adhesives, detergents and cosmetics. FinSMEs
Prof. Riesner Investments
Prof. Riesner has made 1 investments. Their latest investment was in evoxx technologies as part of their Series A on July 7, 2010.
Prof. Riesner Investments Activity